Basal cell carcinoma

Postgraduate Medical Journal

Volumn 73, Issue 863, 1997, Pages 538-542

  Lear, J T ^a   Smith, A G ^a  

^a North Staffs NHS Trust   (United Kingdom)

Author keywords

Basal cell carcinoma; Skin cancer; Ultraviolet radiation

Indexed keywords

AGE; BASAL CELL CARCINOMA; CANCER RECURRENCE; CANCER RISK; CAUCASIAN; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GENDER; HAIR COLOR; HUMAN; MELANOMA; REVIEW; RISK FACTOR; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; ULTRAVIOLET RADIATION; UNITED STATES;

EID: 0030768782     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.73.863.538     Document Type: Review

References (51)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30: 774-8.
2. Boring CC, Squires TS, Tong T. Cancer statistics, 1993. CA Cancer J Clin 1993; 43: 7-26.
3. Russell-Jones R. Ozone depletion and cancer risk. Lancet 1987; 2: 443-6.
4. Scotto J, Fears TR, Fraumeni JF. Incidence of non-melanoma skin cancer in the United States. National Cancer Institute: NIH Publ No 83-2433, 1983.
5. Marks R. An overview of skin cancers. Cancer 1995; 75: 607-12.
6. Kaldor J, Shugg D, Young B, Dwyer T, Wang YG. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance. Int J Cancer 1993; 53: 886-91.
7. Ko CB, Walton S, Keczes K, Bury HPR, Nicholson C. The emerging epidemic of skin cancer. Br J Dermatol 1994; 130: 269-72.
8. Dahl E, Aberg M, Rausing A, Rausing EA. Basal cell carcinoma. Cancer 1992; 70: 104-8.
9. Coebergh JWW, Neumann HAM, Vrints LW, Van Der Heijden L, Meijer WJ, Verhagen-Teulings MTh. Trends in the incidence of non-melanoma skin cancer in the SE Netherlands 1975-1988: a registry based study. Br J Dermatol 1991; 125: 353-9.
10. Betti R, Inselvini E, Carducci M, CrostiC. Age and site prevalence of histologic subtypes of basal cell carcinomas. Int J Dermatol 1995; 34: 174-6.
11. Czarnecki D, Zalcberg J, Meehan C, et al. Familial occurrence of multiple nonmelanoma skin cancer. Cancer Genet Cytogenet 1992; 61: 1-5.
12. Belisano JC. The malignant tumours of the skin. Aust J Dermatol 1954; 1: 179-206.
13. Wicking C, Berkman J, Wainwright B, Chenevix-Trench G. Fine genetic mapping of the gene for naevoid basal cell carcinoma syndrome. Genomics 1994; 22: 505-11.
14. Yeh S, How SW, Lin CS. Arsenical cancer of the skin. Cancer 1968; 21: 312-39.
15. McHenry PM, Aitchison T, MacKie RM. Risk factors for basal cell carcinoma and squamous cell carcinoma. Br J Dermatol 1995; 133 (suppl 45): 29.
16. Lin AN, Carter DM. Skin cancer in the elderly. Dermatol Clin 1986; 4: 467-71.
17. Hogan DJ, To T, Gran L. Risk factors for basal cell carcinoma. Int J Dermatol 1989; 28: 591 -4.
18. Karagas MR, for the Skin Cancer Prevention Study Group Occurrence of cutaneous basal cell and squamous cell malignancies among those with a prior history of skin cancer. J Invest Dermatol 1994; 102: 10S-13S.
19. Karagas MR, Greenberg ER. Unresolved issues in the epidemiology of basal cell and squamous cell skin cancer. In: Mukhtar H, ed, Skin cancer: mechanisms and human relevance. Boca Raton, Florida: CRC Press, 1995; pp79-86.
20. Marghoob AA, Slade J, Salopek TG, Kopf AW, Bart RS, Rigel DS. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Cancer 1995; 75: 707-14.
21. Lindelhof B, Sigurgeirsson B, Wallberg P, Eklund G. Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol 1991; 25: 245-8.
22. Holman CDJ, Armstrong BK. Pigmentary traits, ethnic origin, benign naevi and family history as risk factors for cutaneous malignant melanoma. JNCI 1984; 72: 257-66.
23. Koh HK, Geller AC, Miller DR, Lew RA. Early detection of melanoma: an ounce of prevention may be a ton of work. J Am Acad Dermatol 1993; 28: 645-7.
24. Lookingbill DP. Yield from a complete skin examination: findings in 1157 new dermatology patients. J Am Acad Dermatol 1988; 18: 31-7.
25. Sandstrom A, Larsson LG, Damber L, Occurrence of other malignancies in patients treated for basal cell carcinoma of the skin. Acta Radiol Oncol 1984; 23: 227-30.
26. Mellor R, Nielsen A, Reymann F. Multiple basal cell carcinoma and internal malignant tumours. Arch Dermatol 1975; 111: 584-5.
27. Boyle J, MacKie RM, Briggs JD, Junior BJR, Aitchison TC. Cancer, warts and sunshine in renal transplant patients: a case control study. Lancet 1984; 1: 702-5.
28. Wei Q, Mutanoski GM, Farmer ER, Hedayati MA, Grossman L. DNA repair related to multiple skin cancers and drug use. Cancer Res 1994; 54: 437-40.
29. Ikic D, Padovan I, Pipic N, et al. Interferon reduces recurrences of basal and squamous cell cancers. Int J Dermatol 1995; 34: 58-60.
30. Fleming ID, Amonette R, Monaghan T, Fleming MD. Principles of management of basal and squamous cell carcinoma of the skin. Cancer 1995; 75: 699-704.
31. Silverman MK, Kopf AW, Grin CM, Bart RS, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodessication. J Dermatol Surg Oncol 1991; 17: 720-6.
32. Chandrasekhar S, Terry JJ. Non-melanoma skin cancer. In: McMurray RJ, Murphy GP, eds, Cancer surgery. Philadelphia: Lippincott, 1994; pp 537-49.
33. Mohs FE. Chemsurgery; microscopically controlled surgery for skin cancer. Springfield (IL): Chas A Thomas, 1978.
34. Svanberg K, Andersson T, Killander D, et al. Photodynamic therapy on non-melanoma malignant tumours of the skin using topical deltaamino laevulinic acid sensitisauon and laser irradiation. Br J Dermatol 1994; 30: 743-51.
35. Cornell RC, Greenway HT, Tucker S. Treatment of basal cell carcinoma with intralesional imerferon. J Arn Acad Dermatol 1990; 23: 694-701.
36. Zitelli JA. Mohs micrographie surgery for skin cancer. Principles Problems Oncol 1992; 6: 1-10.
37. Dixon AY, Lee SH, McGregor DH. Histologic features predictive of basal cell carcinoma recurrence: results of a multivariate analysis. J Cutan Pathol 1993; 20: 137-42.
38. Wilder RB, Shimm DS, Kittelson JM, Rogoff EE, Cassady R. Recurrent basal cell carcinoma treated with radiation therapy. Arch Dermatol 1991; 127: 1668-72.
39. Scanlon EF, Volkmer DD, Oveido MA. Metastatic basal cell carcinoma. J Surg Oncol 1980; 5: 171-80.
40. Amonette RA, Salasche SJ, Chesney TM, Clarendon CC. Metastatic basal cell carcinoma. J Dermatol Surg Oncol 1981; 7: 397-400.
41. Snow SN, Sahl W, Lo JS, et al. Metastatic basal cell carcinoma. Cancer 1994; 73: 328-35.
42. Lo JS, Snow SN, Reizner GT, Mohs FE, Larson PO, Hruza GJ. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol 1991; 24: 715-9.
43. Von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. J Am Acad Dermatol 1984; 10: 1043-60.
44. Strickland PT. Photocarcinogenesis by near UVA radiation in Sencar mice. J Invest Dermatol 1986; 87: 272-5.
45. De Gruijl FR, Van Der Meer JB, Van DER Leun JC. Dose-time dependency of skin tumour induction by chronic UV exposure. Photochem Photobiol 1983; 37: 53-62.
46. Kricker A, Armstrong BK, English DR. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control 1994; 5: 367-92.
47. Vitasa BC, Taylor HR, Strickland PT, et al. Association of non-melanoma skin cancer and actinic keratoses with cumulative solar UV exposure in Maryland watermen. Cancer 1990; 65: 2811-7.
48. Hunter DJ, Colditz GA, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Risk factors for basal cell carcinoma in a prospective cohort of women. Ann Epidemiol 1990; 1: 13-23.
49. Kricker A, Armstrong BK, English DR, Heenan PJ. Does intermittent sun exposure cause basal cell carcinoma? Int J Cancer 1995; 60: 489-94.
50. Gallagher RP, Hill GB, Bajdik CD, et al, Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. 1 Basal cell carcinoma Arch Dermatol 1995; 131: 157-63.
51. Naylor MF, Boyd A, Smith DW, et al. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995; 131: 170-5.